29 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C … that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted
ARS
c04tmp1 5ee39g
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
12zpoxgxu
11 Apr 23
Preliminary proxy
5:49pm
S-3
EX-4.4
lw7w4z2f byb6ywqr
24 Aug 22
Shelf registration
4:07pm
S-3
EX-4.5
ywy1isk 95
24 Aug 22
Shelf registration
4:07pm
DEF 14A
3g8fq9
26 Apr 22
Definitive proxy
4:39pm
10-K
b9sjw0p
22 Mar 22
Annual report
5:20pm
10-Q
ix55fbhww724aie4mpg
7 Sep 21
Quarterly report
8:48am
424B4
98r65
23 Jul 21
Prospectus supplement with pricing info
4:49pm
CORRESP
u2l 2l3bwg3xue1
19 Jul 21
Correspondence with SEC
12:00am